Article Details
Retrieved on: 2022-07-13 21:03:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Moderna (MRNA) doses the first participant in the phase I study of its investigational mRNA vaccine, targeting the Nipah virus.
Article found on: www.zacks.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here